Adjuvance Technologies
Lincoln
About Adjuvance Technologies
Adjuvance is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. Adjuvants are critical components that are added to many vaccines to improve the immune response.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2020)
- Website: adjuvancetechnologies.com
- Phone: 4028175050
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/adjuvance-technologies-42295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.